Switching Lexapro Timing and Dose While Discontinuing Wellbutrin
You can switch Lexapro from 20 mg at bedtime to morning dosing, but reducing the dose to 15 mg is not recommended as this is a non-standard dose that may compromise therapeutic efficacy. When discontinuing Wellbutrin, taper it over 10-14 days rather than stopping abruptly.
Recommended Approach
Lexapro Dose Considerations
The FDA-approved dosing for Lexapro is 10 mg or 20 mg once daily 1. A 15 mg dose is not a standard therapeutic dose and lacks supporting evidence for efficacy. If you're considering dose reduction:
- If staying at 20 mg: This is the maximum recommended dose and may be necessary if the patient required this dose for adequate response
- If reducing dose: Drop to 10 mg (the standard therapeutic dose), not 15 mg 1
- Dose reductions should only occur if the patient has been stable for at least 9 months and you're reassessing the need for continued medication 2
Timing Switch for Lexapro
Lexapro can be administered either morning or evening without affecting efficacy 1. The timing choice should be based on:
- Morning dosing: May be preferable if the patient experiences insomnia or activation, as escitalopram can increase alertness and reduce daytime sleepiness 3
- Evening dosing: Better if sedation is desired, though escitalopram is generally less sedating than other antidepressants
Simply switch the timing directly—no taper needed for time-of-day changes 1.
Discontinuing Wellbutrin
Taper bupropion over 10-14 days to minimize withdrawal symptoms 2. Given that bupropion is activating and should not be taken late in the day to minimize insomnia risk 2, if the patient is taking it at night, this is already non-standard dosing.
Discontinuation approach:
- Reduce the dose by approximately 50% for 7 days
- Then reduce to 25% for another 7 days before stopping
- Monitor for withdrawal symptoms including mood changes, irritability, or depression recurrence
Critical Safety Considerations
Why This Matters
Bupropion has significantly higher toxicity in overdose compared to SSRIs 4. In adolescent overdoses, bupropion was associated with:
- Death (0.23% vs 0% for SSRIs)
- Seizures (27.0% vs 8.5%)
- Need for intubation (4.9% vs 0.3%)
If this patient has any suicidal ideation or history of self-harm, discontinuing bupropion may actually reduce overdose risk.
Combination Therapy Evidence
If the patient is currently on both medications for depression, be aware that escitalopram-bupropion combination therapy has shown superior efficacy to monotherapy 5, 6. Discontinuing bupropion may result in:
- Loss of therapeutic benefit from the combination
- Potential relapse of depressive symptoms
- Need for dose optimization of escitalopram alone
Before discontinuing bupropion, ensure the patient has been stable and consider whether monotherapy with escitalopram alone will be sufficient.
Monitoring Requirements
After making these changes:
- Assess within 1-2 weeks for withdrawal symptoms from bupropion and any changes in depression/anxiety symptoms 7
- Monitor for discontinuation syndrome from the Lexapro dose reduction if you choose to reduce (dizziness, fatigue, irritability, sensory disturbances) 8, 1
- If reducing Lexapro dose and symptoms worsen, resume the previous 20 mg dose 1
- Continue monitoring every 2-4 weeks until stable on the new regimen
Common Pitfalls to Avoid
- Don't use 15 mg Lexapro: This non-standard dose lacks evidence and may fall between therapeutic levels
- Don't abruptly stop bupropion: Taper over 10-14 days 2
- Don't reduce Lexapro dose unless clinically indicated: If the patient needed 20 mg for response, reducing may cause relapse
- Don't make both changes simultaneously: Consider switching Lexapro timing first, stabilize for 1-2 weeks, then taper bupropion to better identify which change causes any emerging symptoms